Asger Wretlind

Herlev, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition.

Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predisposition.

Journal: medRxiv : the preprint server for health sciences

Published: May 18, 2026

Steroid hormones in Alzheimer's disease: a molecular analysis of blood and cerebrospinal fluid.

Steroid hormones in Alzheimer's disease: a molecular analysis of blood and cerebrospinal fluid.

Journal: Alzheimer's research & therapy

Published: April 01, 2026

Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.

Impact of Albuminuria-Lowering Treatments on Cardiovascular Predictive Ceramides in Diabetes: Post Hoc Analysis of the ROTATE Trials.

Journal: Diabetes, obesity & metabolism

Published: March 28, 2026

Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism.

Alcohol-related liver disease disrupts bile acid homeostasis and gut microbial bile acid metabolism.

Journal: JHEP reports : innovation in hepatology

Published: January 03, 2026

Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease.

Lipid profiling reveals unsaturated lipid reduction in women with Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: March 11, 2025

Alterations in the brain lipidome of Alzheimer's disease donors with rare TREM2 risk variants.

Alterations in the brain lipidome of Alzheimer's disease donors with rare TREM2 risk variants.

Journal: Brain communications

Published: December 05, 2024

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

Journal: Computers in biology and medicine

Published: January 04, 2024

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials.

Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials.

Journal: Lipids in health and disease

Published: July 04, 2023

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.

Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.

Journal: Diabetes

Published: January 18, 2023

Human Cerebrospinal Fluid Sample Preparation and Annotation for Integrated Lipidomics and Metabolomics Profiling Studies.

Human Cerebrospinal Fluid Sample Preparation and Annotation for Integrated Lipidomics and Metabolomics Profiling Studies.

Journal: Molecular neurobiology

Published: December 07, 2022

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: September 06, 2022

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial.

Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial.

Journal: Frontiers in clinical diabetes and healthcare

Published: January 17, 2022

Showing 1-12 of 21

Last Updated: 09/26/2026